Zhu X G, Yu C L, McPhie P, Wong R, Cheng S Y
Division of Cancer Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Endocrinology. 1996 Feb;137(2):712-21. doi: 10.1210/endo.137.2.8593822.
The clinical manifestations of patients with resistance to thyroid hormone result from inhibition of the functions of wild-type thyroid hormone receptors (wTRs) by the dominant negative effect of mutant TR beta 1 receptors (mTR beta 1). One of the proposed mechanisms by which mTR beta 1 exerts its dominant negative action is via formation of the putative inactive wTR beta 1/mTR beta 1 heterodimer. However, the nature of the wTR beta 1/mTR beta 1 heterodimer is poorly understood. The present study characterizes the wTR beta 1/mTR beta 1 heterodimer by electrophoretic mobility shift assay. The mutant TR beta 1 used was PV, which contains a frame shift mutation in the C-terminal part of TR beta 1 and has less than 1% of the T3 binding affinity of the wTR beta 1. Because of the difficulty in resolving wTR beta 1 and mutant PV dimers, we used a truncated wTR beta 1 in which the A/B domain was deleted (delta TR beta 1) to demonstrate the formation of the heterodimer on thyroid hormone response elements (TREs) in which the half-site binding motifs are oriented in an inverted repeat (F2), a direct repeat separated by four nucleotides (DR4), or an inverted repeat (Pal). Deletion of the A/B domain had no effect on the binding of T3 and TREs to wTR beta 1. In the presence of equal amounts of delta TR beta 1 and PV, three types of molecular complexes. delta TR beta 1 homodimer, delta TR beta 1/PV heterodimer, and PV homodimer bound to each TRE in a ratio of approximately 1:2:1. The identities of these complexes were confirmed by their ability to be supershifted by anti-TR beta 1 and/or anti-PV antibodies. delta TR beta 1/PV heterodimer formation varied with different TREs. The ratio of apparent affinity constant (Ka) in the binding of delta TR beta 1/PV to TREs was F2:DR4:Pal = approximately 6:2:1. The effect of T3 on delta TR beta 1/PV heterodimer formation was TRE dependent. No T3-induced dissociation was observed for the delta TR beta 1/PV heterodimer when bound to F2 and Pal. In contrast, the delta TR beta 1/PV heterodimer bound to DR4 was dissociated by T3 with an ED50 of 3.9 +/- 0.9 nM. The T3-induced dissociation of delta TR beta 1 homodimer bound to F2, DR4, and Pal had ED50 values of 4.1 +/- 1.2, 1.3 +/- 0.3, and more than 100 nM, respectively. By transfection assays, the dominant negative action of PV was found to be TRE dependent with the rank order of F2 >> Pal > ME (a DR4-like TRE in the rat malic enzyme gene). Taken together, these results indicate a strong correlation between wTR beta 1/mTR beta 1 heterodimer formation and the dominant negative potency of PV. These results suggest that the wTR beta 1/mTR beta 1 heterodimer could play an important role in the dominant negative action of mTR beta 1.
甲状腺激素抵抗患者的临床表现是由突变型TRβ1受体(mTRβ1)的显性负效应抑制野生型甲状腺激素受体(wTRs)的功能所致。mTRβ1发挥其显性负作用的一种推测机制是通过形成假定的无活性wTRβ1/mTRβ1异二聚体。然而,对wTRβ1/mTRβ1异二聚体的性质了解甚少。本研究通过电泳迁移率变动分析对wTRβ1/mTRβ1异二聚体进行了表征。所使用的突变型TRβ1是PV,它在TRβ1的C末端部分含有移码突变,其T3结合亲和力不到wTRβ1的1%。由于难以分辨wTRβ1和突变型PV二聚体,我们使用了缺失A/B结构域的截短型wTRβ1(δTRβ1)来证明在甲状腺激素反应元件(TREs)上异二聚体的形成,其中半位点结合基序以反向重复(F2)、由四个核苷酸隔开的直接重复(DR4)或反向重复(Pal)排列。A/B结构域的缺失对T3和TREs与wTRβ1的结合没有影响。在等量的δTRβ1和PV存在的情况下,三种类型的分子复合物,即δTRβ1同二聚体、δTRβ1/PV异二聚体和PV同二聚体以大约1:2:1的比例与每个TRE结合。这些复合物的身份通过它们被抗TRβ1和/或抗PV抗体超迁移的能力得到证实。δTRβ1/PV异二聚体的形成因不同的TREs而异。δTRβ1/PV与TREs结合时的表观亲和常数(Ka)之比为F2:DR4:Pal = 约6:2:1。T3对δTRβ1/PV异二聚体形成的影响取决于TRE。当与F2和Pal结合时,未观察到T3诱导的δTRβ1/PV异二聚体解离。相反,与DR4结合的δTRβ1/PV异二聚体被T3解离,ED50为3.9±0.9 nM。T3诱导的与F2、DR4和Pal结合的δTRβ1同二聚体解离的ED50值分别为4.1±1.2、1.3±0.3和超过100 nM。通过转染实验,发现PV的显性负作用取决于TRE,其顺序为F2 >> Pal > ME(大鼠苹果酸酶基因中的一个DR4样TRE)。综上所述,这些结果表明wTRβ1/mTRβ1异二聚体的形成与PV的显性负效应之间存在很强的相关性。这些结果表明wTRβ1/mTRβ1异二聚体可能在mTRβ1的显性负作用中发挥重要作用。